Literature DB >> 1843394

Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests.

V A de Souza1, C S Pannuti, L M Sumita, P Albrecht.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for measles antibodies was compared with Plaque Neutralization (PRN), Haemagglutination inhibition (HI) and Fluorescent antibody (IFA) tests in 181 sera from vaccinated children and umbilical cord. Of 179 positive samples by the sensitive PRN, only two, with titers of 8, were negative by ELISA (copositivity of 98.9%). IFA and HI presented, respectively, copositivities of 93.3% and 82.7%. The ELISA presented a high sensitivity as well as a good reproducibility and represents an alternative for the time consuming PRN for detection of low measles antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1843394     DOI: 10.1590/s0036-46651991000100007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  3 in total

1.  Measles antibody prevalence after mass immunization in São Paulo, Brazil.

Authors:  C S Pannuti; J C Moraes; V A Souza; M C Camargo; N T Hidalgo
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.

Authors:  Cláudio S Pannuti; Ricardo José Morello; José Cássio de Moraes; Suely Pires Curti; Ana Maria S Afonso; Maria Cláudia Corrêa Camargo; Vanda A U F de Souza
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Authors:  S Ratnam; V Gadag; R West; J Burris; E Oates; F Stead; N Bouilianne
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.